🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Heather Lau

Yale University

ORCID: 0000-0003-1690-9457

Also affiliated with Ultragenyx Pharmaceutical (United States)

MedicineBiochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07)”.

104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07)

Journal of Neurology(2024)10.1007/s00415-024-12236-0

N/A

0.803DataRank · unranked

28 citations

Priya S. Kishnani, Drago Bratkovic, Barry J. Byrne, Kristl G. Claeys, Jordi Díaz‐Manera +79 more

Patients with Gaucher disease display systemic oxidative stress dependent on therapy status

Molecular Genetics and Metabolism Reports(2020)10.1016/j.ymgmr.2020.100667

N/A

0DataRank · unranked

25 citations

Márcia R. Terluk, Roland Brown, Abigail Travis, Usha Mishra, Kyle Rudser +5 more

Clinical outcome assessments of disease burden and progression in late-onset GM2 gangliosidoses

Molecular Genetics and Metabolism(2024)10.1016/j.ymgme.2024.108512

N/A

0DataRank · unranked

9 citations

Camille Rochmann, Pascal Minini, Florian Eichler, Christopher D. Stephen, Heather Lau +6 more